Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, Moll AC, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab and Ranibizumab in Diabetic Macular Edema Study Group. Vader MJC, et al. Among authors: van lith verhoeven jjc. Ophthalmol Retina. 2020 Aug;4(8):777-788. doi: 10.1016/j.oret.2020.02.008. Epub 2020 Feb 27. Ophthalmol Retina. 2020. PMID: 32362552 Free article. Clinical Trial.
Dominant cystoid macular dystrophy.
Saksens NT, van Huet RA, van Lith-Verhoeven JJ, den Hollander AI, Hoyng CB, Boon CJ. Saksens NT, et al. Ophthalmology. 2015 Jan;122(1):180-91. doi: 10.1016/j.ophtha.2014.07.053. Epub 2014 Sep 26. Ophthalmology. 2015. PMID: 25267528
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, de Jong-Hesse Y, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group. Vader MJC, et al. Among authors: van lith verhoeven jjc. Ophthalmol Retina. 2020 Jun;4(6):576-587. doi: 10.1016/j.oret.2019.12.019. Epub 2020 Jan 7. Ophthalmol Retina. 2020. PMID: 32107188 Free article. Clinical Trial.
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.
van Asten F, Evers-Birkenkamp KU, van Lith-Verhoeven JJ, de Jong-Hesse Y, Hoppenreijs VP, Hommersom RF, Scholten AM, Hoyng CB, Klaver JH; HELIOS study group. van Asten F, et al. Acta Ophthalmol. 2015 Mar;93(2):126-33. doi: 10.1111/aos.12610. Epub 2014 Dec 9. Acta Ophthalmol. 2015. PMID: 25488348 Free article.
Reply: To PMID 25267528.
Saksens NT, van Huet RA, van Lith-Verhoeven JJ, den Hollander AI, Hoyng CB, Boon CJ. Saksens NT, et al. Ophthalmology. 2015 Oct;122(10):e60. doi: 10.1016/j.ophtha.2015.04.003. Ophthalmology. 2015. PMID: 26398059 No abstract available.
Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.
van Asten F, de Jong-Hesse Y, van Lith-Verhoeven JJC, Verbraak FD, Vromans JGF, Lau NC, Altemark A, Hoyng CB. van Asten F, et al. Among authors: van lith verhoeven jjc. Acta Ophthalmol. 2019 Mar;97(2):e323-e324. doi: 10.1111/aos.13946. Epub 2018 Oct 14. Acta Ophthalmol. 2019. PMID: 30318723 Free article. No abstract available.
The benign concentric annular macular dystrophy locus maps to 6p12.3-q16.
van Lith-Verhoeven JJ, Hoyng CB, van den Helm B, Deutman AF, Brink HM, Kemperman MH, de Jong WH, Kremer H, Cremers FP. van Lith-Verhoeven JJ, et al. Invest Ophthalmol Vis Sci. 2004 Jan;45(1):30-5. doi: 10.1167/iovs.03-0392. Invest Ophthalmol Vis Sci. 2004. PMID: 14691150
Genetic etiology and clinical consequences of complete and incomplete achromatopsia.
Thiadens AA, Slingerland NW, Roosing S, van Schooneveld MJ, van Lith-Verhoeven JJ, van Moll-Ramirez N, van den Born LI, Hoyng CB, Cremers FP, Klaver CC. Thiadens AA, et al. Ophthalmology. 2009 Oct;116(10):1984-9.e1. doi: 10.1016/j.ophtha.2009.03.053. Epub 2009 Jul 9. Ophthalmology. 2009. PMID: 19592100
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Arnould L, Viola F, Zarranz-Ventura J, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Ophthalmol Retina. 2022 Nov;6(11):1044-1053. doi: 10.1016/j.oret.2022.05.008. Epub 2022 May 16. Ophthalmol Retina. 2022. PMID: 35589075 Free article.
23 results